(Q38454611)

English

Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status

scientific article published on 06 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1 reference

based on heuristic

inferred from title

author name string

Yenna Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Soo Lim

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Eun-Shil Hong

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Jung Hee Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Min Kyung Moon

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Eun Ju Chun

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sang Il Choi

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Young-Bum Kim

8

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Young Joo Park

9

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Kyong Soo Park

10

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Hak C Jang

11

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sung Hee Choi

12

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

6 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

80

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

57-64

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Identification of a novel FGF, FGF-21, preferentially expressed in the liver

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

FGF-21 as a novel metabolic regulator

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

FGF21 is an Akt-regulated myokine

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Fibroblast growth factor 21 corrects obesity in mice

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Distinct association of serum FGF21 or adiponectin levels with clinical parameters in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Relation between fibroblast growth factor-21, adiposity, metabolism, and weight reduction

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Serum levels of the adipokine FGF21 depend on renal function

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Serum fibroblast growth factor-21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Liver fat but not other adiposity measures influence circulating FGF21 levels in healthy young adult twins.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Pericardial fat amount is an independent risk factor of coronary artery stenosis assessed by multidetector-row computed tomography: the Korean Atherosclerosis Study 2.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Comprehensive evaluation of coronary arteries by multidetector-row cardiac computed tomography according to the glucose level of asymptomatic individuals

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Prevalence of noncalcified coronary plaques by 64-slice computed tomography in patients with an intermediate risk for significant coronary artery disease.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Quantification of coronary artery calcium using ultrafast computed tomography.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Standards of medical care in diabetes--2011.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

The link between fibroblast growth factor 21 and sterol regulatory element binding protein 1c during lipogenesis in hepatocytes

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Circulating fibroblast growth factor 21 levels are closely associated with hepatic fat content: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Contribution of glucose tolerance and gender to cardiac adiposity

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12134

21 January 2018

Identifiers

10.1111/CEN.12134

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38454611&oldid=2066238475"